HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

sialyl-lactotetraosylceramide

a marker of undifferentiated human pluripotent stem cells; structure in first source

Also Known As:

IV3NeuAcLc4Cer; sialyl-lactotetra

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycoconjugates: 1353
  - Glycolipids: 2799
    - Glycosphingolipids: 1659
      - Acidic Glycosphingolipids: 20
        Gangliosides: 3319
        sialyl-lactotetraosylceramide: 1
Lipids: 114793
- Glycolipids: 2799
  - Glycosphingolipids: 1659
    - Acidic Glycosphingolipids: 20
      - Gangliosides: 3319
        sialyl-lactotetraosylceramide: 1
- Membrane Lipids: 1591
  - Sphingolipids: 3208
    - Glycosphingolipids: 1659
      - Acidic Glycosphingolipids: 20
        Gangliosides: 3319
        sialyl-lactotetraosylceramide: 1

Experts

1.	Barone, Angela: 1 article (01/2020)
2.	Blixt, Ola: 1 article (01/2020)
3.	Köster Larsen, Rasmus: 1 article (01/2020)
4.	Linder, Anna: 1 article (01/2020)
5.	Mateoiu, Constantina: 1 article (01/2020)
6.	Sundfeldt, Karin: 1 article (01/2020)
7.	Teneberg, Susann: 1 article (01/2020)

Related Diseases

1.	Carcinoma (Carcinomatosis) 01/01/2020 - "In the present study, glycosphingolipids were isolated from human high-grade serous ovarian carcinoma, whereby the novel stem cell marker Sialyl-lactotetra (S-Lc4) was characterized in two out of three cases. "
2.	Neoplasms (Cancer) 01/01/2020 - "Evaluation of Sialyl-Lactotetra as a Marker for Epithelial Ovarian Tumors."

Related Drugs and Biologics

1.	Glycosphingolipids